October 22, 2020

Mobile test lab helps detect COVID-19 at UNH satellite campuses

UNH-Manchester officials said the test has a number of advantages over other testing protocols, including its cost, which is about one-third what the university used to pay. The mobile test lab can supply results in about 30 minutes.
Covid-19 Test
October 20, 2020

DetectaChem Aids Safe Return to Campus with Rapid COVID-19 Testing

DetectaChema Returning Competitor to the 2020 ‘ASTORS’ Homeland Security Awards Program, is pleased to announce the company’s MobileDetect Bio (MD-Bio) BCC19 COVID-19 tests are being successfully deployed by prestigious colleges and universities in the U.S. to help support a safe return to campus for students and staff.
America Security Today
October 15, 2020
DetectaChem Is one of 11 companies racing to make coronavirus test that cost as little as $5 and deliver results in under 15 minutes
DetectaChem has funds from the NIH to scale up production of
rapid tests for healthcare settings, COO Travis Kisner told Business
Insider. Outside of the pandemic, the company does a lot of work
with the military and police to test for drugs and explosives.
Business Insider
October 1, 2020
DetectaChem Threat Detection Technology Expands to COVID-19 Campus Testing
“UNH used DetectaChem’s solution to provide a fast, molecular test with rapid turnaround time. It helped us solve a bottleneck during move-in for students that had not yet received their required lab diagnostic results in time. We could give those students same-day results and continue with their move-in process,” said Marc Sedam, Vice Provost for Innovation and New Ventures at UNH


Sept. 24 2020

From Bombs to SARS-CoV-2: One Company’s COVID-19 Pivot Story

DetectaChem’s experience with bomb and drug detection technology enabled them to quickly pivot during the pandemic. The company’s smartphone-based COVID-19 test is currently advancing through the NIH RADx initiative.


Covid-19 Test
Covid-19 (Sars-CoV-2) Test
 Sept. 22, 2020
DetectaChem Smartphone-Based COVID-19 Test Advances Through NIH RADx (Rapid Acceleration of Diagnostics) Program
DetectaChem, the global leader in innovative portable threat detection solutions used extensively by the U.S. Department of Defense and Homeland Security, today announces that their MD-Bio (MobileDetect Bio) BCP19 Test Pouch for COVID-19 detection successfully passed the initial Deep Dive phase in July 2020 and is currently advancing quickly through Phase 1 of the NIH (National Institutes of Health) RADxSM (Rapid Acceleration of Diagnostics) Tech initiative. PRNewswire


Detectachem Receives FDA EUA Authorization for MobileDetect Bio, Covid-19 (SARS-CoV-2) Smartphone Test Kit

View the BCC19 FDA EUA Authorization

COVID-19 ( SARS-CoV-2 ) Detection Kit
Sept. 3, 2020
DetectaChem Receives FDA EUA Authorization for Mobile COVID-19 Detection Technology
DetectaChem, the global leader in innovative portable threat detection technologies used daily by U.S. Homeland Security, Department of Defense and first responder agencies around the world, today announces their MobileDetect Bio (MD-Bio) BCC19 COVID-19 test kit has received FDA (Food and Drug Administration) EUA (Emergency Use Authorization).


Sept. 3, 2020
DetectaChem gets FDA EUA status for mobile Covid-19 detection technology
The MobileDetect BioBCC19 Covid-19 test applies portable laboratory-grade diagnostic technology that holds the capacity to run up to 96 tests per device in 30 minutes


Sept. 3, 2020
Detectachem wins EUA for rapid COVID-19 test kit
Detectachem Inc. has scored an emergency use authorization (EUA) from the U.S. FDA to market a new molecular RNA test kit for SARS-CoV-2 that provides color-coded results in about 30 minutes.
Sept. 3, 2020
FDA Issues EUAs for Detectachem, Optolane Technologies Coronavirus Tests, Color Collection Kit
NEW YORK — The US Food and Drug Administration on Tuesday granted separate Emergency Use Authorizations for molecular SARS-CoV-2 tests developed by Detectachem and Optolane Technologies, as well as a nasal swab self-collection kit from Color Genomics.


Sept. 3, 2020
FDA Issues EUAs for Detectachem, Optolane Technologies Coronavirus Tests, Color Collection Kit
Detectachem’s MobileDetect Bio BCC19 Test Kit uses reverse transcription loop-mediated isothermal nucleic acid amplification to detect the N and E genes of SARS-CoV-2 in nasopharyngeal, anterior nasal, mid-turbinate nasal, and oropharyngeal swab specimens.
360 Dx


Sept. 3, 2020
FDA authorizes mobile COVID-19 test kit
The FDA has issued emergency use authorization (EUA) for a mobile COVID-19 test kit developed by handheld detection system maker DetectaChem.


MobileDetectBIO Mobile Experience
April 1, 2020

DetectaChem Creates First Mass-Market Smartphone COVID-19 Test Kit